Evidence map›Paper›PMID 38576979›Full record

ArticleAnnals of medicine and surgery (2012)2024

Prevalence of fetomaternal Rhesus incompatibility at the tertiary care hospital: a cross-sectional study.

Olivier Nyakio, Fabrice Kibukila, Tarun Kumar Suvvari, Priyadarshini Bhattacharjee, Aymar Akilimali, Denis Mukwege

Open access · diamondAbstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 6 countries.

Olivier NyakioFaculty of Medicine, Evangelic University in Africa.
Fabrice KibukilaFaculty of Medicine, Official University of Bukavu, Bukavu.
Tarun Kumar SuvvariDepartment of Medicine, Rangaraya Medical College, Kakinada, Andhra Pradesh, India.
Priyadarshini BhattacharjeeDepartment of Clinical Medicine, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK.
Aymar AkilimaliDepertment of Research, Medical Research Circle (MedReC).
Denis MukwegeFaculty of Medicine, Evangelic University in Africa.
Cambridge University Hospitals NHS Foundation Trust · GBGreen Circle · CZRangaraya Medical College · INSociety for Maternal-Fetal Medicine · USUniversité Evangélique en Afrique · CDUniversité Officielle de Bukavu · CD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Fetomaternal Rhesus incompatibility is a medical condition that affects the pregnant woman [of blood group (A, B, AB, O) and a negative Rhesus] and the foetus (of positive Rhesus). The objective of this study is to determine the prevalence and to present the clinical characteristics of fetomaternal Rhesus incompatibility in a tertiary care hospital. Methods: The authors conducted a retrospective cross-sectional study and 37 participants were recorded during the study period of 4 years. Results: A total of 11 898 pregnant women admitted to the maternity and 37 of them (women with blood groups A, B, AB or O and with a negative Rhesus) participated in our study, including a frequency of 0.31%. Thirty cases of fetomaternal Rhesus incompatibility were recorded in new-borns. 27 (73%) of the women are from the urban region and the age group between 21 and 25 is the most affected with 37.8%. Twenty-two (59.5%) of pregnant women have blood group O (and negative Rhesus) and primiparous women are the most affected with 64.9%. For the discovery of allo-immunization, 43.2% of women discovered it during the second pregnancy and 48.7% women received a single infusion of Anti-D serum during the first pregnancy. Twelve (40%) new-borns developed jaundice as a perinatal prognosis. Conclusion: Fetomaternal Rhesus incompatibility remains a major problem of maternal health because it is likely to lead to the formation of antibodies in women, which by crossing the placental barrier, they destroy red blood cells and thus cause serious complications.

Indexed as

Femalefoetal bloodhemoglobinopathiesphenotypepregnancyprevalence

Identifiers

PMID38576979
PMCPMC10990368
OpenAlexW4392191159

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.